YANG Zhanjiang, DU Guangqing, LI Congying, et al. Application Rationality of Tigecycline for Injection in 99 Patients[J]. 2022,22(1):97-100. DOI: 10.14009/j.issn.1672-2124.2022.01.020.
OBJECTIVE: To probe into the application rationality of tigecycline for injection in inpatients in a tertiary rehabilitation hospital based on clinical-rehabilitation dual pathway management
so as to provide references for clinical rational medication. METHODS: Retrospectively analysis was conducted on the medical records of 99 patients using tigecycline for injection who were consulted at rehabilitation pharmacy center in this hospital from Jan. 2018 to May 2021
patients ’ general information
pathogenic examination
drug sensitivity test
medication rationality
clinical efficacy and incidence of adverse drug reactions were analyzed. RESULTS: The patients using tigecycline for injection in this hospital was mostly elderly male
and the overall number of patients was increasing year by year.Among the 99 patients
84 cases underwent pathogenic examination
and the delivery specimens were mainly sputum;totally 132 case-times of pathogenic bacteria were detected
mainly were Klebsiella pneumoniae
Acinetobacter baumannii and Pseudomonas aeruginosa
all of which showed high drug resistance; the clinical effective rate was78. 79%( 78 cases)
and the incidence of adverse drug reactions was 5. 05%( 5 cases); the usage and dosage
route of administration and drug combination were all reasonable; 2 cases( 2. 02%) were basically reasonable
mainly for empirical medication; 20 cases( 20. 20%) were irrational medication
mainly for unreasonable indications and medication regimen. CONCLUSIONS: The clinical treatment effect of tigecycline for injection is good
with few adverse drug reactions. The main types of irrational drug application in this hospital are improper indications and medication regimen
the clinic should strengthen drug management
continuously carry out training on rational application of antibiotics to avoid drug abuse and improve the level of clinical rational drug application.